| 产品详情 |
| Edit |   |
|---|
| Product Name | Apolipoprotein C-III, Human |
|---|
| Description | Purity ~95% (SDS-PAGE). Apo CIII inhibits the activation of lipoprotein lipase by Apo CII. Reduced levels of Apo CIII result in higher fatty acid uptake from plasma triglycerides into adipose tissue. Thus, Apo CIII is a potential target for treatment of obesity and insulin resistance. The normal plasma concentration of Apo CIII is 8-15mg per 100ml. Source: Human plasma (Shown to be non reactive for HBsAg, anti-HCV, anti-HBc, and negative for anti-HIV 1 & 2 by FDA approved tests.) |
|---|
| Size | 100ug |
|---|
| Concentration | n/a |
|---|
| Applications | n/a |
|---|
| Other Names | Apolipoprotein C-III, Human (Apolipoprotein CIII, Apo CIII, Apo C-III, ApoC III, ApoCIII, Apo-CIII, ApoC-III, Apolipoprotein C3, APOC 3, APOC3, MGC150353) |
|---|
| Gene, Accession, CAS # | n/a |
|---|
| Catalog # | A2299-68N |
|---|
| Price | |
|---|
| Order / More Info | Apolipoprotein C-III, Human from UNITED STATES BIOLOGICAL |
|---|
| Product Specific References | n/a |
|---|
| 产品资料 |
|
|